• Tues news: Prostate cancer trials to watch. Merck’s subcutaneous Keytruda. Apellis sees positive in Astellas CRL. Future of Medicare price negotiations. JNJ psoriasis results. See more on our front page

Chemguy

Gender
Male

Followers

Trophies

  1. 2

    Somebody Likes You

    Somebody out there reacted positively to one of your messages. Keep posting like that for more!
  2. 1

    First Message

    Post a message somewhere on the site to receive this.